David Howat
Nessuna posizione attualmente
Storia della carriera di David Howat
Precedenti posizioni note di David Howat
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Direttore/Membro del Consiglio | 30/03/2012 | 21/10/2015 |
| Corporate Officer/Principal | 30/03/2012 | 21/10/2015 | |
| THERACRYF PLC | Corporate Officer/Principal | - | - |
| K.S. Biomedix Holdings Plc | Corporate Officer/Principal | - | - |
| NICOX SA | Corporate Officer/Principal | - | - |
Celltech Chiroscience Plc
 Celltech Chiroscience Plc Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech Chiroscience Plc is a research-based pharmaceutical group. | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
| Regno Unito | 5 |
| Francia | 2 |
Posizioni
| Corporate Officer/Principal | 5 |
| Director/Board Member | 1 |
Settori
| Health Technology | 3 |
| Health Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NICOX SA | Health Technology |
| THERACRYF PLC | Health Services |
| Aziende private | 3 |
|---|---|
Celltech Chiroscience Plc
Celltech Chiroscience Plc Miscellaneous Commercial ServicesCommercial Services Part of UCB SA, Celltech Chiroscience Plc is a research-based pharmaceutical group. | Commercial Services |
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
| K.S. Biomedix Holdings Plc | Health Technology |
- Borsa valori
- Insiders
- David Howat
- Esperienza
